Skip To The Main Content

FDA-Approved Drugs

The following drugs have been approved since the year 2000 for the treatment of non-Hodgkin's lymphoma:

Treanda (bendamustine)

FDA approved October 2008

Bendamustine is a chemotherapy drug approved for the treatment of B-cell non-Hodgkin lymphomas.

Arranon (nelarabine)

FDA approved October 2005

This chemotherapy drug is approved for the treatment of T-cell lymphoblastic lymphoma.

Bexxar (tositumomab)

FDA approved June 2003

This drug is a monoclonal antibody that targets specific lymphoma cells. Tositumomab is linked to a radioactive agent called iodine-131 (I-131). The medicine allows radiation to be delivered directly to the sites of the lymphoma.

Zevalin (ibritumomab tiuxetan)

FDA approved February 2002

This drug is a protein that targets specific lymphoma cells. To be effective ibritumomab tiuxetan is linked to a radioactive agent called yttrium chloride (Y-90). The medicine allows radiation to be delivered directly to the sites of the lymphoma.

mammogram

MetroWest Medical Center provides advanced medicine and personalized care, right here in your community.

Learn More

vip-program

Become a VIP (Very Important Patient) and get free access to a trained Personal Health Guide.

Learn More

heartvascular

The Center for Heart & Vascular Services. At the forefront of heart and vascular disease for more than 25 years.

Learn More